Rapport Therapeutics Inc.... (RAPP)
NASDAQ: RAPP
· Real-Time Price · USD
10.16
-0.66 (-6.10%)
At close: May 27, 2025, 2:14 PM
Rapport Therapeutics Common Stock Revenue
Rapport Therapeutics Common Stock reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending March 31, 2025, Rapport Therapeutics Common Stock generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
0%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
69
Market Cap
370.98M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|